Sarah Verhoeff

Chapter 1 General introduction and outline of this thesis	7
Chapter 2 Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT in patients with newly diagnosed metastatic clear cell renal cell carcinoma.	23
Chapter 3 The value of [89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to predict watchful waiting duration in patients with metastatic clear cell renal cell carcinoma.	43
Chapter 4 Programmed Cell Death-1/Ligand-1 PET Imaging: A Novel Tool to Optimize Immunotherapy?	67
Chapter 5 [89Zr]Zr-DFO-durvalumab PET/CT before durvalumab treatment in patients with recurrent or metastatic head and neck cancer	81
Chapter 6 [89Zr]Zr-DFO-avelumab PET/CT in early-stage non-small cell lung carcinoma patients to predict neo-adjuvant avelumab treatment response.	111
Chapter 7 Towards a better understanding of immune checkpoint inhibitor in radiolabeled PET-imaging studies.	129
Chapter 8 Summary, general discussion and future perspectives	137
Chapter 9 Nederlandse samenvatting	151
List of publications	158
PhD portfolio	160
Research datamanagement	162
Dankwoord	164
Curriculum vitae	168

Made with FlippingBook

RkJQdWJsaXNoZXIy MTk4NDMw